Burley Brewton was able to count on a new advancement in targeted therapy after he was diagnosed with prostate cancer, the ...

BPH is the fifth most prevalent non-cancer disorder among men 50 years and older (Rev Urol. 2006;8 [Suppl 3]:S9-S15). Office visits for BPH increased from 10,116 per 100,000 patients in 1994 to 14,473 ...

ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...

U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring(R) Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as ...

Before having cataract surgery, any person who has ever taken an alpha blocker should tell their eye surgeon. Tamsulosin is ...

Treatments for prostate cancers localised to the prostate have long been aimed at treating the whole prostate either by ...

Benign prostatic hyperplasia (BPH) remains a significant clinical condition affecting ageing men worldwide, characterised by enlargement of the prostate gland and associated lower urinary tract ...

Discover the innovative minimally invasive surgical techniques (MISTs) reshaping BPH treatment. Learn about benefits, patient ...

MINNETONKA, Minn.—American Medical Systems (AMS) has launched the MoXy Liquid Cooled Fiber for laser treatment of benign prostatic hyperplasia (BPH). Designed to be used with the recently launched ...

The recent development in laser technology has permitted the emergence of effective surgical procedures to cure enlarged prostate. In this context, American Medical Systems, a provider of world-class ...